Skip to content
Company
Science
Investors
News
Contact
Company
Science
Investors
News
Contact
Posts in Science
by
gene001web
May 27, 2022
GeneTether Therapeutics Announces Issuance of New US Composition of Matter Patent for its Innovative Platform Technology Focused on Gene Editing Efficiency
San Lorenzo, California and Vancouver, British Columbia – May 25, 2022
0
read more
by
gene001web
May 16, 2022
GeneTether Therapeutics Publishes Paper on Novel Recombination Products in the CFTR Gene
San Lorenzo, California – May 11, 2022
0
read more
by
gene001web
March 14, 2022
GeneTether Therapeutics Inc. Receives Notice of Allowance from USPTO
Vancouver, British Columbia – February 14, 2022
0
read more
by
gene001web
February 18, 2021
GeneTether TNT™ Platform Granted Australian Patent
Berkeley, CA, February 18, 2021
0
read more
